- Report
- June 2024
- 200 Pages
Global
From €5648EUR$6,360USD£4,934GBP
€7060EUR$7,950USD£6,168GBP
- Report
- September 2022
- 115 Pages
Global
From €5329EUR$6,000USD£4,655GBP
€6661EUR$7,500USD£5,819GBP
- Report
- September 2022
- 62 Pages
Global
From €2806EUR$3,160USD£2,452GBP
€3508EUR$3,950USD£3,065GBP
- Report
- October 2024
- 200 Pages
Global
From €3330EUR$3,750USD£2,909GBP
- Report
- March 2024
- 200 Pages
Global
From €3686EUR$4,150USD£3,220GBP
- Report
- January 2024
- 200 Pages
Global
From €3686EUR$4,150USD£3,220GBP
- Report
- February 2022
- 167 Pages
Global
From €3952EUR$4,450USD£3,452GBP
- Report
- July 2024
- 118 Pages
Global
From €4218EUR$4,750USD£3,685GBP
- Report
- February 2024
- 110 Pages
Global
From €4218EUR$4,750USD£3,685GBP
- Report
- January 2024
- 150 Pages
Global
From €3419EUR$3,850USD£2,987GBP
€4307EUR$4,850USD£3,763GBP
- Report
- April 2023
- 120 Pages
Global
From €4218EUR$4,750USD£3,685GBP
- Report
- November 2023
- 110 Pages
Global
From €3996EUR$4,500USD£3,491GBP
- Report
- December 2024
- 145 Pages
Global
From €3508EUR$3,950USD£3,065GBP
- Report
- April 2023
- 147 Pages
Global
From €4395EUR$4,949USD£3,840GBP
- Report
- August 2024
- 240 Pages
Global
From €4395EUR$4,949USD£3,840GBP
- Report
- February 2024
- 380 Pages
Global
€4436EUR$4,995USD£3,875GBP
- Report
- May 2024
- 127 Pages
Global
From €4436EUR$4,995USD£3,875GBP
- Report
- February 2020
- 44 Pages
Asia Pacific
From €3104EUR$3,495USD£2,712GBP
- Report
- January 2024
- 140 Pages
Global
From €3996EUR$4,500USD£3,491GBP
- Report
- November 2023
- 86 Pages
Global
From €3996EUR$4,500USD£3,491GBP

The Stem Cell Transplant market is a subset of the larger stem cell industry. It involves the use of stem cells to treat a variety of diseases and conditions, including cancer, blood disorders, and genetic diseases. Stem cell transplants are used to replace damaged or diseased cells with healthy ones, and can be used to treat a variety of conditions.
The stem cell transplant market is a rapidly growing field, with new treatments and technologies being developed and tested. Companies in the market are focused on developing and commercializing stem cell therapies, as well as providing services related to stem cell transplantation. These companies include Celgene, Novartis, and Osiris Therapeutics. Additionally, there are a number of smaller companies that are focused on developing and commercializing stem cell therapies, such as Athersys, Inc., and Pluristem Therapeutics. Show Less Read more